Dear MNN members,

 

Please note.

 

Tabrez

 

From: Julie Lefebvre <julie.lefebvre@sickkids.ca>
Sent: Monday, October 2, 2023 8:19 PM
To: info@manitobaneuroscience.ca
Subject: could you please forward this IBRO RISING STAR AWARD in NEUROSCIENCE opportunity for new faculty to your Neuroscience network?

 

 

Hello, 

 

I am reaching out to you to ask whether you could distribute this info to your Neuroscience colleagues regarding an IBRO Award competition for early career faculty in a Neuroscience-related field.

 

I am a representative on the IBRO (International Brain Research Organization) US/CANADA Regional Committee.  We have a call for applications for its IBRO Rising Star Award, for early career faculty in Canada and the US. There are two awards, 1 for US, and 1 for Canada, for 45,000 EUR.  The Award is for early career faculty in a neuroscience-related field from diverse and/or underrepresented backgrounds, and who do not have substantial start-up funds or grant support from other agencies. The Application deadline is October 11th, 2023.

 

The IBRO Rising Stars Awards aim to increase the successful transition and retention of diverse, early-career neuroscientists into academic positions by providing funds to make a significant difference in their research endeavors.

 

The award supports the research needs of early career faculty from diverse and/or underrepresented backgrounds (racial/ethnic minorities, sexual orientation, disability, etc) and early career faculty who do not have substantial start-up funds or grant support from other agencies.

 

Website and application link:

 

 

 

 

 

Thank you

Julie

 

 

 

 

Julie L. Lefebvre PhD

Canada Research Chair in Neural Circuit Development

Senior Scientist, Program for Neuroscience & Mental Health

Hospital for Sick Children Research Institute  

Associate Professor of Molecular Genetics, 

University of Toronto

686 Bay St. PGCRL 5-9-707

Toronto, ON  M5G0A4

Tel: 416-813-7654  x309248

 

 


This e-mail may contain confidential, personal and/or health information(information which may be subject to legal restrictions on use, retention and/or disclosure) for the sole use of the intended recipient. Any review or distribution by anyone other than the person for whom it was originally intended is strictly prohibited. If you have received this e-mail in error, please contact the sender and delete all copies.